Update on the management of hypophosphatasia

Ther Adv Musculoskelet Dis. 2019 Aug 1:11:1759720X19863997. doi: 10.1177/1759720X19863997. eCollection 2019.

Abstract

Hypophosphatasia is a rare inherited disease caused by a loss of function mutations in the gene that codes for the tissue-nonspecific alkaline phosphatase enzyme. It is autosomally inherited and at least 388 different genetic defects have been identified. The clinical presentation is variable from a severe perinatal form, that is fatal if untreated, to adult-onset disease. This review covers the pathophysiology, diagnosis and current management option including the recently licensed enzyme replacement therapy asfotase alfa.

Keywords: alkaline phosphatase; asfotase alfa; hypophosphatasia; osteomalacia; rickets.

Publication types

  • Review